These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 18237197
1. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3. Geurts N, Martens E, Van Aelst I, Proost P, Opdenakker G, Van den Steen PE. Biochemistry; 2008 Feb 26; 47(8):2689-99. PubMed ID: 18237197 [Abstract] [Full Text] [Related]
2. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Vandooren J, Van den Steen PE, Opdenakker G. Crit Rev Biochem Mol Biol; 2013 Feb 26; 48(3):222-72. PubMed ID: 23547785 [Abstract] [Full Text] [Related]
3. Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B. Rosenblum G, Van den Steen PE, Cohen SR, Grossmann JG, Frenkel J, Sertchook R, Slack N, Strange RW, Opdenakker G, Sagi I. Structure; 2007 Oct 26; 15(10):1227-36. PubMed ID: 17937912 [Abstract] [Full Text] [Related]
4. Gelatinase B functions as regulator and effector in leukocyte biology. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J. J Leukoc Biol; 2001 Jun 26; 69(6):851-9. PubMed ID: 11404367 [Abstract] [Full Text] [Related]
5. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. Schönbeck U, Mach F, Libby P. J Immunol; 1998 Oct 01; 161(7):3340-6. PubMed ID: 9759850 [Abstract] [Full Text] [Related]
6. Construction, expression, and characterization of a baculovirally expressed catalytic domain of human matrix metalloproteinase-9. Sadatmansoori S, MacDougall J, Khademi S, Cooke LS, Guarino L, Meyer EF, Forough R. Protein Expr Purif; 2001 Dec 01; 23(3):447-52. PubMed ID: 11722182 [Abstract] [Full Text] [Related]
7. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. Illman SA, Lehti K, Keski-Oja J, Lohi J. J Cell Sci; 2006 Sep 15; 119(Pt 18):3856-65. PubMed ID: 16940349 [Abstract] [Full Text] [Related]
8. Protease analysis by neoepitope approach reveals the activation of MMP-9 is achieved proteolytically in a test tissue cartilage model involved in bone formation. Lee ER, Lamplugh L, Kluczyk B, Mort JS, Leblond CP. J Histochem Cytochem; 2006 Sep 15; 54(9):965-80. PubMed ID: 16709729 [Abstract] [Full Text] [Related]
9. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2. Jani M, Tordai H, Trexler M, Bányai L, Patthy L. Biochimie; 2005 Sep 15; 87(3-4):385-92. PubMed ID: 15781326 [Abstract] [Full Text] [Related]
10. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R. Biochem Biophys Res Commun; 2003 Aug 22; 308(2):386-95. PubMed ID: 12901881 [Abstract] [Full Text] [Related]
11. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. Olson MW, Bernardo MM, Pietila M, Gervasi DC, Toth M, Kotra LP, Massova I, Mobashery S, Fridman R. J Biol Chem; 2000 Jan 28; 275(4):2661-8. PubMed ID: 10644727 [Abstract] [Full Text] [Related]